UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3801
iShares MSCI Israel ETF
EIS
$808M
| $7.08M | ﹤0.01% |
58,661
-24,295
| -29% | -$3.11M |
2014 Q4
46 quarters
|
|
3802
CALL
Entergy
ETR
$52.8B
| $7.08M | ﹤0.01% |
+61,600
| New | +$6.94M |
2026 Q2
0 quarters
|
|
3803
PAR Technology
PAR
$850M
| $7.07M | ﹤0.01% |
405,912
+70,156
| +21% | +$1.01M |
2019 Q2
28 quarters
|
|
3804
Triumph Financial Inc
TFIN
$1.46B
| $7.06M | ﹤0.01% |
92,470
-177,295
| -66% | -$12.1M |
2015 Q3
43 quarters
|
|
3805
Silvercorp Metals
SVM
$1.97B
| $7.05M | ﹤0.01% |
698,009
-445,163
| -39% | -$5.37M |
2017 Q2
36 quarters
|
|
3806
State Street SPDR Bloomberg Short Term International Treasury Bond ETF
BWZ
$297M
| $7.03M | ﹤0.01% |
262,757
+69,767
| +36% | +$1.89M |
2014 Q4
46 quarters
|
|
3807
WisdomTree US LargeCap Fund
EPS
$1.59B
| $7.02M | ﹤0.01% |
90,272
+2,912
| +3% | +$221K |
2014 Q4
46 quarters
|
|
3808
Jack in the Box
JACK
$270M
| $7.02M | ﹤0.01% |
443,755
+365,161
| +465% | +$4.5M |
2014 Q4
46 quarters
|
|
3809
Defiance Quantum ETF
QTUM
$4.65B
| $7.01M | ﹤0.01% |
42,408
+30,736
| +263% | +$4.42M |
2024 Q3
7 quarters
|
|
3810
Nuveen Floating Rate Income Fund
JFR
$1.18B
| $7M | ﹤0.01% |
912,982
-1,706
| -0.2% | -$12.9K |
2014 Q4
46 quarters
|
|
3811
Immunome
IMNM
$2.21B
| $6.96M | ﹤0.01% |
328,493
-104,419
| -24% | -$2.23M |
2024 Q1
9 quarters
|
|
3812
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$2.89B
| $6.96M | ﹤0.01% |
709,357
-6,689
| -0.9% | -$62.7K |
2014 Q4
46 quarters
|
|
3813
PUT
Vista Energy
VIST
$6.35B
| $6.95M | ﹤0.01% |
109,000
| – | – |
2026 Q1
1 quarter
|
|
3814
Eaton Vance Tax-Managed Buy-Write Opportunities Fund
ETV
$1.64B
| $6.95M | ﹤0.01% |
467,155
-58,682
| -11% | -$854K |
2014 Q4
46 quarters
|
|
3815
DELISTED
Avanos Medical
AVNS
| $6.95M | ﹤0.01% |
279,381
+146,646
| +110% | +$3.43M |
2014 Q4
46 quarters
|
|
3816
Baron First Principles ETF
RONB
$363M
| $6.94M | ﹤0.01% |
284,469
+261,619
| +1,145% | +$6.18M |
2025 Q4
2 quarters
|
|
3817
CALL
Cameco
CCJ
$31.1B
| $6.94M | ﹤0.01% |
68,110
+45,010
| +195% | +$5.05M |
2026 Q1
1 quarter
|
|
3818
Biglari Holdings Class A
BH.A
$1B
| $6.94M | ﹤0.01% |
3,296
+2,692
| +446% | +$4.42M |
2023 Q3
11 quarters
|
|
3819
CALL
Amprius Technologies
AMPX
$1.27B
| $6.93M | ﹤0.01% |
500,000
+400,000
| +400% | +$7.17M |
2026 Q1
1 quarter
|
|
3820
Sutro Biopharma
STRO
$160M
| $6.92M | ﹤0.01% |
208,512
-184,359
| -47% | -$5.75M |
2022 Q1
17 quarters
|
|
3821
Pelagos Insurance Capital
PLGO
$2.29B
| $6.92M | ﹤0.01% |
284,045
-269,101
| -49% | -$5.85M |
2023 Q3
11 quarters
|
|
3822
CALL
AngloGold Ashanti
AU
$47B
| $6.9M | ﹤0.01% |
85,300
+85,000
| +28,333% | +$8.07M |
2025 Q1
5 quarters
|
|
3823
Alphabet Inc Depositary Shares Series B Preferred Stock
GOOGN
| $6.88M | ﹤0.01% |
+136,816
| New | +$6.86M |
2026 Q2
0 quarters
|
|
3824
NWPX Infrastructure Inc
NWPX
$841M
| $6.88M | ﹤0.01% |
45,863
+15,404
| +51% | +$1.69M |
2022 Q4
14 quarters
|
|
3825
BBVA Argentina
BBAR
$2.16B
| $6.87M | ﹤0.01% |
350,242
+125,134
| +56% | +$2.11M |
2020 Q4
22 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,281 new, 4,217 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,281 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.